APA (7th ed.) Citation

Pang, F., Dean, R., Jensen, I., Tehard, B., Roze, S., Olaye, A., . . . Miller, B. (2022). EE24 The Cost-Effectiveness of Atidarsagene Autotemcel for the Treatment of Metachromatic Leukodystrophy (MLD) in France. Value in Health, 25(7), S339. https://doi.org/10.1016/j.jval.2022.04.276

Chicago Style (17th ed.) Citation

Pang, F., R. Dean, I. Jensen, B. Tehard, S. Roze, A. Olaye, K. Bean, and B. Miller. "EE24 The Cost-Effectiveness of Atidarsagene Autotemcel for the Treatment of Metachromatic Leukodystrophy (MLD) in France." Value in Health 25, no. 7 (2022): S339. https://doi.org/10.1016/j.jval.2022.04.276.

MLA (9th ed.) Citation

Pang, F., et al. "EE24 The Cost-Effectiveness of Atidarsagene Autotemcel for the Treatment of Metachromatic Leukodystrophy (MLD) in France." Value in Health, vol. 25, no. 7, 2022, p. S339, https://doi.org/10.1016/j.jval.2022.04.276.